These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


107 related items for PubMed ID: 830762

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Structural studies of the protein portion of the H-2-linked Ia glycoprotein antigens of the mouse: tryptic peptide comparison of products from the I-A and I-C subregions of B10-HTT.
    Freed JH, David CS, Shreffler DC, Nathenson SG.
    J Immunol; 1978 Jul; 121(1):91-7. PubMed ID: 78948
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Biochemical studies on the H-2K antigens of the MHC mutants bm3 and bm11.
    Ewenstein BM, Uehara H, Nisizawa T, Melvold RW, Kohn HI, Nathenson SG.
    Immunogenetics; 1980 Jul; 11(4):383-95. PubMed ID: 7429601
    [Abstract] [Full Text] [Related]

  • 27. Cytotoxic T lymphocyte response to minor H-42a alloantigen in H-42b mice: clonal inactivation of the precursor cytotoxic T lymphocytes by veto-like spleen cells that express the H-42a antigen.
    Ishikawa H, Hino T, Kato H, Suzuki H, Saito K.
    J Immunol; 1986 Oct 01; 137(7):2080-8. PubMed ID: 3489752
    [Abstract] [Full Text] [Related]

  • 28. Cytotoxic T lymphocyte response to minor H-43a alloantigen in H-43b mice. Privileged H-2Kb restriction to the response is not due to immunodominance or epistatic effect but due to Ir gene function of H-2Kb itself.
    Hino T, Ishikawa H, Saito K.
    J Immunol; 1988 Jan 01; 140(1):44-51. PubMed ID: 3121741
    [Abstract] [Full Text] [Related]

  • 29. [In vivo activity of cytotoxic lymphocytes directed against the product of gene H-2Kb and its mutant alleles].
    Nikonenko BV, Pospelov LE.
    Biull Eksp Biol Med; 1981 Apr 01; 91(4):479-80. PubMed ID: 7020792
    [Abstract] [Full Text] [Related]

  • 30. Biochemical comparison of MHC antigens isolated from mutant C3HfB/HeN and parent C3H/HeN mice.
    Callahan GN, Martin WJ, Pardi D.
    J Immunol; 1982 May 01; 128(5):2116-20. PubMed ID: 7061856
    [Abstract] [Full Text] [Related]

  • 31. Biochemical studies of H-2K antigens from a group of related mutants. I. Identification of a shared mutation in B6-H-2bm5 and B6-H-2bm16.
    Yamaga KM, Pfaffenbach GM, Pease LR, McGovern D, Nisizawa T, Melvold RW, Kohn HI, Nathenson SG.
    Immunogenetics; 1983 May 01; 17(1):19-29. PubMed ID: 6826207
    [Abstract] [Full Text] [Related]

  • 32. AKR/J gene(s) unlinked to H-2 determines dominant inheritance of lymphocyte hyporesponsiveness to acetylcholine receptor.
    Gorzynski TJ, Lennon VA, Nathanson RM, David CS.
    J Immunol; 1985 Apr 01; 134(4):2079-83. PubMed ID: 3919088
    [Abstract] [Full Text] [Related]

  • 33. Structural differences between the mouse H-2D products of the mutant B10.D2.M504 (H-2da) and the parental nonmutant strain B10.D2 (H-2d).
    Brown JL, Nairen R, Natherson SG.
    J Immunol; 1978 Mar 01; 120(3):726-33. PubMed ID: 632584
    [No Abstract] [Full Text] [Related]

  • 34. A mutation in a non-MHC murine cell surface antigen detectable by cytotoxic T lymphocytes.
    Rinchik EM, Amos DB.
    J Immunol; 1986 Mar 15; 136(6):1992-8. PubMed ID: 3485137
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT, Kobs-Conrad S, Seo YH, Lee H, VanBuskirk AM, Feng N, Sheridan JF, Stevens V.
    J Mol Recognit; 1993 Jun 15; 6(2):81-94. PubMed ID: 7508238
    [Abstract] [Full Text] [Related]

  • 38. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
    Hori S, Sato S, Kitagawa S, Azuma T, Kokudo S, Hamaoka T, Fujiwara H.
    J Immunol; 1989 Sep 01; 143(5):1447-52. PubMed ID: 2527264
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Analysis of somatic cell H-2 variants to define the structural requirements for class I antigen expression.
    Zeff RA, Gopas J, Steinhauer E, Rajan TV, Nathenson SG.
    J Immunol; 1986 Aug 01; 137(3):897-903. PubMed ID: 3722821
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.